ARID1A loss in tumor cells induces R-loops, which give rise to cytosolic DNA species that activate STING-type I IFN signaling, inducing an ARID1A–IFN gene expression signature that promotes anti-tumor immunity [47]. Here, STING1 is linked to neoplasm.